New Jersey is investing in the next generation of life sciences companies with a new $10 million fund aimed at helping startups grow, create jobs and expand the state’s role in health and biotechnology innovation.
The New Jersey Economic Development Authority and RWJBarnabas Health announced the new investment Monday to support companies connected to the New Jersey Innovation Hub and the HELIX Strategic Innovation Center in New Brunswick.
The fund will provide capital and support for early-stage life sciences companies working to bring new research, technologies and medical innovations to market.
Gov. Mikie Sherrill highlighted the announcement on X, saying the partnership will help innovative companies “start and thrive right here in New Jersey.”
She said the collaboration between NJEDA and RWJBarnabas Health is designed to support entrepreneurs while strengthening New Jersey’s long-standing position as a major center for life sciences.
According to the announcement, the $10 million fund will support companies affiliated with the HELIX innovation ecosystem, where researchers, universities, health systems and private companies are being brought together under one broader development strategy.
The goal is not only to finance promising startups, but also to help keep new companies and jobs in New Jersey as they move from early research into commercial development.
Life sciences remain one of New Jersey’s most important industries, with the state already home to major pharmaceutical, biotechnology and health care companies.
State leaders say investments like this are intended to make sure smaller and younger companies have a better chance to grow locally rather than leaving New Jersey in search of funding and infrastructure elsewhere.
The new fund adds another piece to the state’s broader effort to build an innovation economy around health care, biotechnology and advanced research.
Source: NJEDA, RWJBarnabas Health; X / Gov. Mikie Sherrill
By NJ RADAR Team